2-Day Alzheimers Disease and Other Neurocognitive Disorders Conference-Update on Risks, Treatment and Evidence-Based Management of Complex Issues – M. Catherine Wollman

In Stock

Original price was: $439.99.Current price is: $132.00.

2-Day Alzheimers Disease and Other Neurocognitive Disorders Conference-Update on Risks, Treatment and Evidence-Based Management of Complex Issues – M. Cath…

Purchase this course you will earn 132 Points worth of $13.20!
Quantity

Buy 2-Day Alzheimers Disease and Other Neurocognitive Disorders Conference-Update on Risks, Treatment and Evidence-Based Management of Complex Issues – M. Catherine Wollman Course at GBesy. We actively participate in Groupbuys and are committed to sharing knowledge with a wider audience. Rest assured, the quality of our courses matches that of the original sale page. If you prefer, you can also buy directly from the sale page at the full price (the SALEPAGE link is directly provided in the post).

Salepage link: At HERE. Archive:

$439.99   $137 – 2-Day Alzheimers Disease and Other Neurocognitive Disorders Conference-Update on Risks, Treatment and Evidence-Based Management of Complex Issues – M. Catherine Wollman

Alzheimer’s disease and other neurocognitive disorders are disabling health conditions that create daunting challenges to patients, families and clinicians.

Are you prepared to manage and anticipate the complex patient needs that emerge when caring for these patients?

Have there been times in the past that you wished you had done more…?

Catherine Wollman, DNP, CRNP, GNP-BC, will provide the very latest research about who’s at risk, what’s at stake, and what we can realistically do to manage the impact of neurocognitive disorders.

Knowledge and evidence in dementia care are constantly changing. We will focus on the newest science, but also the use of ingenuity and compassion to address the multiple problems facing patients and families.

Unique clinical challenges will be reviewed using personal stories and case studies to decide the best pharmacological and non-pharmacological interventions to transform your own practice.

Alzheimer’s disease and other neurocognitive disorders will touch almost all of us personally or professionally.

During this intense recording, Catherine will provide you with new clinical insights and critical thinking skills so that you won’t need to feel uncertain, frustrated or at risk anymore!


  1. Differentiate cognitive impairment, dementias, neurocognitive disorders and their unique symptoms and trajectories.
  2. Review new DSM5™ changes and updated research on neurocognitive disorders.
  3. Evaluate the current status of dementia research, including new risks, causes and prevention of Alzheimer’s disease.
  4. Summarize screening tools and diagnostic methods for neurocognitive disorders.
  5. Recognize the impact of neurocognitive disorders/ dementias on the individual, family, caregivers and healthcare providers.
  6. Develop a comprehensive interdisciplinary plan of care for the patient and family with neurocognitive disorders/ dementias.
  7. Synthesize evidence-based interventions for behavioral and psychological symptoms of dementia.
  8. Discuss pharmacologic therapy for neurocognitive disorders/ dementias, delirium and depression.
  9. Summarize clinical updates on delirium from prevention and early recognition to effective management.
  10. Examine ethical issues related to neurocognitive disorders including capacity, safety, diagnosis disclosure, palliative and end of life care.
  11. Improve quality of life and outcomes of care for patients and families with neurocognitive disorders/ dementias.
  12. Analyze case studies of complex patients with neurocognitive disorders/ dementias.

Neurocognitive Disorders, Dementia and Cognitive Impairment

  • DSM-5™ changes and terminology
  • Aging and neurodegeneration
  • New research related to pathophysiology, diagnosis, risk factors and prevention

Differentiate Neurodegenerative Disorders

  • Alzheimer’s disease
  • Vascular disease
  • Frontotemporal disorder
  • Lewy body disease
  • Traumatic Brain Injury

Update on Delirium

  • Acute or persistent delirium
  • Screening and diagnosis
  • Prevent life threatening consequences
  • Evidence-based medications and treatment
  • Long term consequences

Diagnosis of Neurocognitive Disorders/Dementias

  • Reversible dementia-like disorders and conditions
  • Validated cognitive screening tools
  • New diagnostic criteria and stages of dementia
  • Family response to diagnosis

Pharmacologic Therapies for Neurocognitive Disorders/Dementias

  • Cholinesterase inhibitors
  • NMDA receptor antagonists
  • Antidepressants
  • Antipsychotics and other psychotropic drugs
  • Evaluate new drugs and learn medications to avoid
  • Consider risk, side effects, and efficacy for older adults

Behavioral and Psychological Symptoms of Dementia (BPSD)

  • Vast majority of patients with one or more BPSD
  • Serious negative consequences of untreated behaviors
  • Tools to systematically assess the presence and severity of symptoms
  • Investigation of multiple contributing factors
  • Interdisciplinary creation and evaluation of a treatment plan

Interventions for Common Distressing Behaviors

  • Agitation, anxiety and restlessness that lead to emotional distress and disability
  • Apathy that contributes to poor prognosis and increased mortality
  • Sexually inappropriate behaviors – one of the most distressing behaviors
  • Frustration of changing behaviors over time

Best Practice for Unique Challenges

  • Eliminate pain-inducing factors to diminish behaviors
  • Nutrition and hydration challenges with disease progression
  • Sleep disorders and evidencebased management
  • Depression and effective therapy
  • Psychotic symptoms: Nonpharmacological and pharmacological interventions

Ethical Issues

  • Safety, function and autonomy
  • Comfort and dignity
  • Advance care planning
  • Palliative care and hospice
  • Genetic testing
  • Disclosure of diagnosis

Patient/Family Needs Across the Disease Trajectory

  • Professional and family caregivers
  • Community Resources

Case Studies and Clinical Stories

$439.99   $137 – 2-Day Alzheimers Disease and Other Neurocognitive Disorders Conference-Update on Risks, Treatment and Evidence-Based Management of Complex Issues – M. Catherine Wollman


Buy the 2-Day Alzheimers Disease and Other Neurocognitive Disorders Conference-Update on Risks, Treatment and Evidence-Based Management of Complex Issues – M. Catherine Wollman course at the best price at GBesy.. After your purchase, you will get access to the downloads page. You can download all the files associated in your order at here and we will also send a download notification email via your mail.

Unlock your full potential with 2-Day Alzheimers Disease and Other Neurocognitive Disorders Conference-Update on Risks, Treatment and Evidence-Based Management of Complex Issues – M. Catherine Wollman courses. our courses are designed to help you excel.

Why wait? Take the first step towards greatness by purchasing 2-Day Alzheimers Disease and Other Neurocognitive Disorders Conference-Update on Risks, Treatment and Evidence-Based Management of Complex Issues – M. Catherine Wollman courses today. We offer a seamless and secure purchasing experience, ensuring your peace of mind. With our trusted payment gateways, Stripe and PayPal, you can confidently complete your transaction knowing that your financial information is protected.

Stripe, known for its robust security measures, provides a safe and reliable payment process. With its encrypted technology, your sensitive data remains confidential throughout the transaction. Rest assured that your purchase is protected.

PayPal, a globally recognized payment platform, offers an additional layer of security. With its buyer protection program, you can feel confident in your purchase. PayPal ensures that your financial details are safeguarded, allowing you to focus on your learning journey.

Is it secure? to Use of?
How can this course be delivered?
What Shipping Methods Are Available?
How Do I Track Order?
  • We always notice the status of your order immediately after your payment. After 7 days if there is no download link, the system will automatically complete your money.
  • We love to hear from you. Please don’t hesitate to email us with any comments, questions and suggestions.
Status

Language

Author

Reviews

There are no reviews yet.

Be the first to review “2-Day Alzheimers Disease and Other Neurocognitive Disorders Conference-Update on Risks, Treatment and Evidence-Based Management of Complex Issues – M. Catherine Wollman”

Your email address will not be published. Required fields are marked *

Back to Top